MONTREAL, October 7, 2025 – CSL Behring Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) have announced signing of a Letter of Intent that sets pricing...
MONTRÉAL, September 19, 2025 – No announcements have been made over the summer on progress in gaining access to two novel hemophilia therapies. Altuviiio for...
The call for applications for the CHS’ research programs for the 2026-2027 grant period is ongoing. The deadline to submit applications for all the programs...
The CHS is very proud to present its latest publication, the first component of its brand-new Novel Therapies Education Program. CLICK HERE to access the online booklet.
In an effort to bring young volunteers into the Canadian Hemophilia Society (CHS), and in recognition that a sound education is of utmost importance, particularly...